NCT04539327 2026-03-18
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Completed
Clinical Trials
471 trialsNCT06221397 2026-03-16
LEGIT_MC_EVCDA
AI Labs Group S.L
Completed
NCT06282991 2026-03-10
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Completed
NCT05968599 2026-02-25
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
Completed
NCT06837090 2026-02-20
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT05383976 2026-02-11
PCSNaP
Abramson Cancer Center at Penn Medicine
Completed
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT05622682 2026-01-26
VIRAL
Children's Hospital of Philadelphia
Completed
NCT04514341 2026-01-14
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
Completed
NCT04872738 2026-01-06
LymphVAX
Massachusetts General Hospital
Completed
NCT05529979 2026-01-06
SaFE
Quantum Surgical
Completed
NCT04317599 2026-01-02
CAPSTAN CRC
Pierre Fabre Medicament
Completed
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT04369053 2025-12-26
PREEMPT CRC
Freenome Holdings Inc.
Completed
NCT04131933 2025-12-23
REaCT-Algorith
Ottawa Hospital Research Institute
Completed
NCT01440465 2025-12-17
NAVI
Centre Francois Baclesse
Completed
NCT01440010 2025-12-12
TARGIT_BQR
Universitätsmedizin Mannheim
Completed
NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT03359759 2025-12-10
e-DomSanté
Institut Bergonié
Completed
NCT03676257 2025-12-10
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Institut Bergonié
Completed
NCT03963531 2025-12-10
METABONE
Institut Bergonié
Completed
NCT03963544 2025-12-10
METAGIST
Institut Bergonié
Completed
NCT04671615 2025-12-10
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
Pfizer
Completed
NCT04735367 2025-12-09
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Pfizer
Completed
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT05366725 2025-12-02
A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT04941768 2025-11-28
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT06086340 2025-11-18
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer
Completed
NCT05376241 2025-10-24
Promoting Informed Choice for Breast Cancer Screening
University of Colorado, Denver
Completed
NCT05643885 2025-10-20
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Pfizer
Completed
NCT06134089 2025-10-20
Evaluating Online Messages About Colon Cancer Screening
University of Utah
Completed
NCT02141438 2025-10-16
REASSURE
Bayer
Completed
NCT04010240 2025-10-16
NTRK
Institut Bergonié
Completed
NCT02874001 2025-10-06
PO-BADO
Institut Bergonié
Completed
NCT03963518 2025-10-06
SURROGATE-ICI
Institut Bergonié
Completed
NCT05599334 2025-10-06
NEAR
Pierre Fabre Medicament
Completed
NCT03676218 2025-10-03
DATECANelderly
Institut Bergonié
Completed
NCT03694171 2025-10-03
Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)
Institut Bergonié
Completed
NCT03833934 2025-10-02
SPACEWALK
Addario Lung Cancer Medical Institute
Completed
NCT04589247 2025-09-25
IMPROVE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed
NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
NCT03977818 2025-09-05
METASARC
Institut Bergonié
Completed
NCT04427280 2025-09-04
CARDS
Royal Marsden NHS Foundation Trust
Completed
NCT02022202 2025-09-03
BEAUTY
Mayo Clinic
Completed
NCT02751827 2025-08-24
PreToxE
Institut Bergonié
Completed
NCT03951220 2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
NCT04952922 2025-08-08
FUNQOLR
Royal Marsden NHS Foundation Trust
Completed